Literature DB >> 20359916

Societal costs of insomnia.

Damien Léger1, Virginie Bayon.   

Abstract

Insomnia is the most common sleeping disorder and has been recognized as a major public health issue, associated with a high societal cost. The aim of this review is firstly to understand how the socio-demographic and career characteristics of insomniacs may influence the economical consequences of this disease. Secondly, it also tries to explain how patients seek help to cope with their insomnia. The review aims to carefully describe the possible links between insomnia and public health concerns as to point out what are the certitudes and the missing data on the consequences of insomnia on work, economics, accidents, costs and health related quality of life (HrQol).
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20359916     DOI: 10.1016/j.smrv.2010.01.003

Source DB:  PubMed          Journal:  Sleep Med Rev        ISSN: 1087-0792            Impact factor:   11.609


  92 in total

1.  Prevalence and correlates of insomnia in a polish sample of alcohol-dependent patients.

Authors:  Nataliya Zhabenko; Marcin Wojnar; Kirk J Brower
Journal:  Alcohol Clin Exp Res       Date:  2012-04-04       Impact factor: 3.455

2.  Sleep symptoms associated with intake of specific dietary nutrients.

Authors:  Michael A Grandner; Nicholas Jackson; Jason R Gerstner; Kristen L Knutson
Journal:  J Sleep Res       Date:  2013-09-02       Impact factor: 3.981

3.  Lack of Resilience Is Related to Stress-Related Sleep Reactivity, Hyperarousal, and Emotion Dysregulation in Insomnia Disorder.

Authors:  Laura Palagini; Umberto Moretto; Martina Novi; Isabella Masci; Danila Caruso; Christopher L Drake; Dieter Riemann
Journal:  J Clin Sleep Med       Date:  2018-05-15       Impact factor: 4.062

4.  Insomnia with Short Sleep Duration: Nosological, Diagnostic, and Treatment Implications.

Authors:  Alexandros N Vgontzas; Julio Fernandez-Mendoza
Journal:  Sleep Med Clin       Date:  2013-09-01

Review 5.  Insomnia in the Elderly: A Review.

Authors:  Dhaval Patel; Joel Steinberg; Pragnesh Patel
Journal:  J Clin Sleep Med       Date:  2018-06-15       Impact factor: 4.062

Review 6.  Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson's disease: insights from a transgenic mouse model.

Authors:  L David Willison; Takashi Kudo; Dawn H Loh; Dika Kuljis; Christopher S Colwell
Journal:  Exp Neurol       Date:  2013-01-24       Impact factor: 5.330

Review 7.  Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder.

Authors:  Alexandros N Vgontzas; Julio Fernandez-Mendoza; Duanping Liao; Edward O Bixler
Journal:  Sleep Med Rev       Date:  2013-02-16       Impact factor: 11.609

8.  Increased prevalence of insomnia and changes in hypnotics use in England over 15 years: analysis of the 1993, 2000, and 2007 National Psychiatric Morbidity Surveys.

Authors:  Maria Calem; Jatinder Bisla; Aysha Begum; Michael Dewey; Paul E Bebbington; Traolach Brugha; Claudia Cooper; Rachel Jenkins; James Lindesay; Sally McManus; Howard Meltzer; Nicola Spiers; Scott Weich; Robert Stewart
Journal:  Sleep       Date:  2012-03-01       Impact factor: 5.849

9.  Short sleep duration is associated with higher energy intake and expenditure among African-American and non-Hispanic white adults.

Authors:  Ruth E Patterson; Jennifer A Emond; Loki Natarajan; Katherine Wesseling-Perry; Laurence N Kolonel; Patricia Jardack; Sonia Ancoli-Israel; Lenore Arab
Journal:  J Nutr       Date:  2014-02-12       Impact factor: 4.798

10.  Sleep-Wake Differences in Relative Regional Cerebral Metabolic Rate for Glucose among Patients with Insomnia Compared with Good Sleepers.

Authors:  Daniel B Kay; Helmet T Karim; Adriane M Soehner; Brant P Hasler; Kristine A Wilckens; Jeffrey A James; Howard J Aizenstein; Julie C Price; Bedda L Rosario; David J Kupfer; Anne Germain; Martica H Hall; Peter L Franzen; Eric A Nofzinger; Daniel J Buysse
Journal:  Sleep       Date:  2016-10-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.